Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor

European Journal of Endocrinology

Volumn 139, Issue 1, 1998, Pages 101-106

  Martin, Malcolm M ^a   Wu, Shao Ming ^a   Martin, Arline L A ^a   Rennert, Owen M ^a   Chan, Wai Yee ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR;

ADULT; ARTICLE; CASE REPORT; FAMILY HISTORY; FOLLITROPIN BLOOD LEVEL; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LEYDIG CELL TUMOR; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RECEPTOR GENE; SEMINOMA; TESTOSTERONE BLOOD LEVEL;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; DNA, NEOPLASM; HUMANS; MALE; MUTATION; PUBERTY, PRECOCIOUS; RECEPTORS, LH; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0031877093     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1390101     Document Type: Article

References (21)

1. Schedewie HK, Reiter EO, Beitins IZ, Seyed S, Wooten VD, Jimenez JF et al. Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. Journal of Clinical Endocrinology and Metabolism 1981 52 271-278.
2. Cutler GB Jr. Overview of premature sexual development. In Sexual Precocity: Etiology, Diagnosis, and Management, pp 1-10. Eds GD Grave & GB Cutler Jr. New York: Raven Press, 1993.
3. Grumbach MM & Styne DM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In Williams Textbook of Endocrinology, edn 8, pp 1139-1208. Eds JD Wilson & DW Foster. New York: WB Saunders, 1992.
4. Rosenthal SM, Grumbach MM & Kaplan SL. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone-acetate therapy in four cases. Journal of Clinical Endocrinology and Metabolism 1983 57 571-579.
5. Chan WY & Cutler GB Jr. Molecular aspects of precocious puberty. Advances in Molecular and Cellular Endocrinolology 1998 2 121-141.
6. Laue L. Ligand-independent hormone secretion. Current Opinion in Pediatrics 1995 7 434-439.
7. Weinstein LS & Shenker A. G protein mutations in human disease. Clinical Biochemistry 1993 26 333-338.
8. Lipsett MB, Wilson H, Kirschner MA, Korenman SG, Fishman LM, Sarfaty GA et al. Studies on Leydig cell physiology and pathology: secretion and metabolism of testosterone. Recent Progress in Hormone Research 1966 22 248-251.
9. Martin MM & Martin ALA. The syndrome of congenital hereditary adrenal hypoplasia and hypogonadotropic hypogonadism. International Journal of Adolescent Medicine and Health 1985 1 119-137.
10. Laue L, Chan WY, Hsueh AJW, Kudo M, Hsu SY, Wu SM et al. Genetic heterogeneity of constitutively activating mutations of the luteinizing hormone receptor in familial male-limited precocious puberty. Proceedings of the National Academy of Sciences of the USA 1995 92 1906-1910.
11. Bar A, Linder B, Sobel EH, Saenger P & Di Martino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. Journal of Pediatrics 1995 126 955-958.
12. Saez J. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocrine Reviews 1994 15 574-626.
13. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR & Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1995 340 692-696.
14. Allen LF, Lefkowitz RJ, Caron MG & Cotecchia S. G-protein-coupled receptor genes as protooncogenes: constitutively activating mutations of the α1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proceedings of the National Academy of Sciences of the USA 1991 88 11354-11358.
15. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J & Vassart G. Genetic basis of endocrine disease. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. Journal of Clinical Endocrinology and Metabolism 1995 80 2577-2585.
16. Rajpert-De Meyts E & Skakkabaek NE. The possible role of sex hormones in the development of testicular cancer. European Urology 1993 23 54-59.
17. Rajpert-De Meyts E, Jørgensen N, Müller J, Giwercman A & Skakkabaek NE. Origin of germ cell tumors. In Sex Differentiation: Clinical and Biological Aspects. Frontiers in Endocrinology 20, Serono Symposia, pp 45-54. Ed IA Hughes. Norwell: Serono Symposium, USA, 1996.
18. Akre O, Ekbom A, Hsieh CC, Trichopoulos D & Adami HO. Testicular nonseminoma and seminoma in relation to perinatal characteristics. Journal of the National Cancer Institiute 1996 88 883-889.
19. Venturelli E, Coradini D, Gornati D & Secreto G. Growth stimulatory effect and metabolism of testosterone in MCF-7 human breast cancer cells. International Journal of Oncology 1996 8 687-692.
20. Morishima A, Grumbach MM, Simpson ER, Fisher C & Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995 80 3689-3698.
21. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM. Specker B et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 1994 331 1056-1061